Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Warsaw - Delayed Quote PLN

Pharmena S.A. (PHR.WA)

4.3100
0.0000
(0.00%)
As of 9:31:43 AM GMT+2. Market Open.
Currency in PLN All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
9,846
9,837
19,022
15,213
9,933
Cost of Revenue
3,896
3,994
8,687
7,381
4,848
Gross Profit
5,950
5,843
10,335
7,832
5,085
Operating Expense
44,395
8,081
10,824
11,856
11,120
Operating Income
-38,445
-2,238
-489
-4,024
-6,035
Net Non Operating Interest Income Expense
995
-81
-892
-439
-244
Pretax Income
-520
34,856
-1,412
-4,457
-6,272
Tax Provision
-766
5,908
204
182
686
Net Income Common Stockholders
-1,617
28,941
-1,570
-4,592
-6,891
Diluted NI Available to Com Stockholders
-1,617
28,941
-1,570
-4,592
-6,891
Basic EPS
-0.14
2.60
-0.14
-0.41
-0.63
Diluted EPS
-0.14
2.60
-0.14
-0.41
-0.63
Basic Average Shares
11,137.7580
11,137.7580
11,137.7580
11,110.0920
10,984.7580
Diluted Average Shares
11,137.7580
11,137.7580
11,137.7580
11,137.7580
11,000.6870
Total Operating Income as Reported
-1,581
34,871
-508
-3,983
-6,008
Total Expenses
48,291
12,075
19,511
19,237
15,968
Net Income from Continuing & Discontinued Operation
-1,617
28,941
-1,570
-4,592
-6,891
Normalized Income
-29,610.0300
-1,877.1940
-1,554.6100
-4,625.2100
-6,912.8700
Interest Income
1,052
496
--
--
--
Interest Expense
-149
371
722
265
204
Net Interest Income
995
-81
-892
-439
-244
EBIT
-669
35,227
-690
-4,192
-6,068
EBITDA
-560
35,552
-129
-3,566
-5,440
Reconciled Cost of Revenue
3,896
3,994
8,687
7,381
4,848
Reconciled Depreciation
109
325
561
626
628
Net Income from Continuing Operation Net Minority Interest
249
28,941
-1,570
-4,592
-6,891
Total Unusual Items Excluding Goodwill
36,863
37,108
-19
41
27
Total Unusual Items
36,863
37,108
-19
41
27
Normalized EBITDA
-37,423
-1,556
-110
-3,607
-5,467
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0002
0.0002
Tax Effect of Unusual Items
7,003.9700
6,289.8060
-3.6100
7.7900
5.1300
12/31/2020 - 2/22/2010

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade